[1] |
XIAO Yi, WU Ming, YAO Gang.
Research progress and future perspectives of tumor organoid
[J]. China Oncology, 2024, 34(8): 763-776.
|
[2] |
JIANG Dan, SONG Guoqing, WANG Xiaodan.
Study on the mechanism of mitochondrial dysfunction and CPT1A/ERK signal transduction pathway regulating malignant behavior in breast cancer
[J]. China Oncology, 2024, 34(7): 650-658.
|
[3] |
LIANG Yingyun, CHEN Jianhua.
Application progress of oncolytic virus combined with immunotherapy in the treatment of malignant tumors
[J]. China Oncology, 2024, 34(7): 686-694.
|
[4] |
CHEN Hongyu, SU Pengyu, LUO Wenzi, PANG Dequan, WANG Feiran.
A study of relationship between cardiac exposure dose-volume and cardiovascular autonomic dysfunction in radiotherapy
[J]. China Oncology, 2024, 34(11): 1036-1044.
|
[5] |
YANG Ziyi, GU Bingxin, XU Xiaoping, SONG Shaoli.
Comparison of 18F-FDG and 68Ga-FAPI PET/CT in the diagnosis of lung metastasis in different malignant tumors
[J]. China Oncology, 2023, 33(9): 829-833.
|
[6] |
Expert Committee on Immunotherapy of Chinese Society of Clinical Oncology , Professional Committee on Cancer Biotherapy of Shanghai Anticancer Association .
Chinese expert consensus on clinical application of recombinant oncolytic adenovirus in the treatment of malignant tumors
[J]. China Oncology, 2023, 33(5): 527-548.
|
[7] |
YANG Ziyi, LI Panli, GU Bingxin, LIU Cheng, SONG Shaoli, XU Xiaoping.
The synthesis of a novel molecular imaging probe 68Ga-DOTA-PDL1P and application in mouse model of melanoma
[J]. China Oncology, 2023, 33(4): 354-360.
|
[8] |
CHEN Zhujun, DING Zhimin, MA Xiaolu, WANG Yanchun, HU Haoyun, LU Renquan, GUO Lin.
Analysis of characteristics of infectious pathogens in malignant tumors combined with bloodstream infection and significance of serum glucose detection
[J]. China Oncology, 2023, 33(10): 927-935.
|
[9] |
Society of Onco-Endocrinology of Chinese Anti-Cancer Association.
Chinese expert consensus on immunotherapy for gynecological malignant tumors (2023 edition)
[J]. China Oncology, 2023, 33(10): 954-967.
|
[10] |
WANG Jian, DING Congcong, LU Yan, LI Tong.
NLK inhibits the transformation from prostatitis to prostate cancer through maintaining NF-κB/P53 functional balance
[J]. China Oncology, 2022, 32(7): 614-623.
|
[11] |
HU Xichun, HU Zhihuang, WANG Biyun, WANG Jialei, TAO Rong, ZHANG Jian, GUO Weijian, CHEN Jie, LUO Zhiguo, LI Ting, HUANG Mingzhu, QIU Lixin, SANG Youzhou.
COVID-19 and systemic anti-cancer therapy
[J]. China Oncology, 2022, 32(6): 499-511.
|
[12] |
ZOU Zijian, SUN Wei, HU Tu, WANG Chunmeng, YAN Wangjun, LUO Zhiguo, LIU Xin, ZHONG Jingqin, LIN Xinyi, XU Yu, CHEN Yong.
Clinical value of sentinel lymph node biopsy in patients with cutaneous and acral melanoma
[J]. China Oncology, 2022, 32(12): 1168-1177.
|
[13] |
JIA Dongdong, LI Tao.
Retrospective analysis of adjuvant therapy with dabrafenib and trametinib for 24 patients with malignant melanoma
[J]. China Oncology, 2022, 32(12): 1178-1183.
|
[14] |
Society of Onco-endocrinology of Chinese Anti-Cancer Association.
Expert consensus on metformin adjuvant therapy in malignant tumor patients with diabetes mellitus type 2 (2022 edition)
[J]. China Oncology, 2022, 32(11): 1121-1132.
|
[15] |
HU Guannan , CHEN Lei , ZHOU Liangping , ZHOU Zhengrong .
A case report of pulmonary malignant melanoma complicated with lung adenocarcinoma and literature review
[J]. China Oncology, 2021, 31(7): 647-650.
|